Stem cells for neurological disease: the same therapy behaves differently depending on where you put it

Neural stem cells, MSCs, and iPSC-derived therapies are being tested across ALS, MS, Parkinson's, Alzheimer's, and spinal cord injury. But the mechanism of benefit—and the clinical results—vary dramatically by condition. What if we're not using the right cells for the right diseases?